Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration
Authors:
- Charles D. NicholsCNCharles D. Nichols
- Efrain E. GarciaEGEfrain E. Garcia
- Elaine Sanders-BushESElaine Sanders-Bush
- 1 March 2003
- journal article
- Published by Elsevier in Molecular Brain Research
- Vol. 111 (1-2) , 182-188
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptorsNeuroscience, 2002
- Synaptic Activity-Induced Conversion of Intronic to Exonic Sequence in Homer 1 Immediate Early Gene ExpressionJournal of Neuroscience, 2002
- Serotonin and HallucinogensNeuropsychopharmacology, 1999
- Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate releaseBrain Research, 1999
- Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitroLife Sciences, 1998
- [3H]MDL 100,907: a novel selective 5-HT2A receptor ligandNaunyn-Schmiedeberg's Archives of Pharmacology, 1996
- In vitroandin vivoprofile of SB 206553, a potent 5‐HT2C/5‐HT2Breceptor antagonist with anxiolytic‐like propertiesBritish Journal of Pharmacology, 1996
- Serotonin, schizophrenia and antipsychotic drug actionSchizophrenia Research, 1995
- Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635European Journal of Pharmacology, 1994
- Visual Phenomenology of the LSD FlashbackArchives of General Psychiatry, 1983